Protective effects of Amaranthus spinosus leaf extract against CCl4-induced hepatorenal injury in rats: Insights from GC-MS analysis

Liver and kidney diseases present significant public health challenges due to limited treatment options, high management costs, and elevated mortality risks. This study evaluates the therapeutic effects of Amaranthus spinosus (A. spinosus) in mitigating CCl₄-induced hepatorenal injury in rats. Twenty-five adult male albino rats were divided into five groups: controls (distilled water and CCl₄), two treatment groups receiving A. spinosus extract (100 mg/kg and 200 mg/kg), and a standard drug group treated with silymarin (100 mg/kg). Biochemical evaluations, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, urea, and creatinine, were analyzed using standard protocols. Antioxidant markers, including reduced glutathione (GSH) levels, along with the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), and lactate dehydrogenase (LDH) were also evaluated. Treatment with ethanolic A. spinosus extract significantly improved biochemical markers, restored antioxidant enzyme activity, and reduced CCl₄-induced hepatorenal damage. Histopathological analysis revealed restored liver and kidney architecture with reduced inflammation. Administration of the extract resulted in a reduction of pro-inflammatory cytokine IL-6 and LDH levels, alongside an increase in anti-inflammatory IL-10 levels, highlighting its anti-inflammatory potential. GC-MS analysis identified 16 bioactive compounds, including fatty acids, esters, phytol, β-panasinsene, squalene, and vitamin E, which likely contribute to its protective effects. These findings suggest that A. spinosus exhibits significant hepatoprotective, nephroprotective, antioxidant, and anti-inflammatory properties, highlighting its potential as a candidate for novel therapies targeting liver and kidney diseases. Further research is needed to elucidate its molecular mechanisms and clinical applications.

Authors

Publication Details

Journal
The Journal of Phytopharmacology
Published
2025-03-23
DOI
https://doi.org/10.31254/phyto.2025.14103
Citations
2
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
3.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protective effects of Amaranthus spinosus leaf extract against CCl4-induced hepatorenal injury in rats: Insights from GC-MS analysis

Olaitan Daniel Johnson, Adewale Akeem Yusuff, Temidayo Ogunmoyole
2 citations
The Journal of Phytopharmacology
Drug-Induced Hepatotoxicity and Protection
3.11
article

Protective effects of Amaranthus spinosus leaf extract against CCl4-induced hepatorenal injury in rats: Insights from GC-MS analysis

Olaitan Daniel Johnson, Adewale Akeem Yusuff, Temidayo Ogunmoyole
article en
2 citations

Abstract

Liver and kidney diseases present significant public health challenges due to limited treatment options, high management costs, and elevated mortality risks. This study evaluates the therapeutic effects of Amaranthus spinosus (A. spinosus) in mitigating CCl₄-induced hepatorenal injury in rats. Twenty-five adult male albino rats were divided into five groups: controls (distilled water and CCl₄), two treatment groups receiving A. spinosus extract (100 mg/kg and 200 mg/kg), and a standard drug group treated with silymarin (100 mg/kg). Biochemical evaluations, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, urea, and creatinine, were analyzed using standard protocols. Antioxidant markers, including reduced glutathione (GSH) levels, along with the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), and lactate dehydrogenase (LDH) were also evaluated. Treatment with ethanolic A. spinosus extract significantly improved biochemical markers, restored antioxidant enzyme activity, and reduced CCl₄-induced hepatorenal damage. Histopathological analysis revealed restored liver and kidney architecture with reduced inflammation. Administration of the extract resulted in a reduction of pro-inflammatory cytokine IL-6 and LDH levels, alongside an increase in anti-inflammatory IL-10 levels, highlighting its anti-inflammatory potential. GC-MS analysis identified 16 bioactive compounds, including fatty acids, esters, phytol, β-panasinsene, squalene, and vitamin E, which likely contribute to its protective effects. These findings suggest that A. spinosus exhibits significant hepatoprotective, nephroprotective, antioxidant, and anti-inflammatory properties, highlighting its potential as a candidate for novel therapies targeting liver and kidney diseases. Further research is needed to elucidate its molecular mechanisms and clinical applications.

The Journal of PhytopharmacologyVol. 14(1)
Openalex Percentile: Top 11%
Drug-Induced Hepatotoxicity and Protection
3.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.